All fields are required.
New Liver Targeted Orally-available Inhibitors of HBV Polymerase.
At lead optimisation/preclinical candidate stage.
Program ready for early co-development/license, contact us for information.
Drug design stage
Ai-biopharma is engaged in the discovery and development of drugs for the treatment of human diseases and Medicinal Chemistry services.
Sep 04 2020 by Ai-biopharma
Aug 20 2020 by Ai-biopharma
May 29 2020 by Ai-biopharma
© Copyright Ai-biopharma S.A.S.